Virtual Reality for Appendectomy Pain

Overview

To determine the impact of VR-Biofeedback and VR-Distraction on pain and medication utilization in children and adolescents undergoing surgery for ruptured appendix.

Full Title of Study: “Functional Response to Immersive Virtual Reality in Pediatric Patients Post-Laparoscopic Appedectomy”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Other
    • Masking: None (Open Label)
  • Study Primary Completion Date: June 2021

Interventions

  • Other: VR-Biofeedback
    • Participants will be instructed to use the Mindful Aurora Application
  • Other: VR-Distraction
    • Participants will be instructed to use one of four applications

Arms, Groups and Cohorts

  • Other: VR-Biofeedback
  • Other: VR-Distraction

Clinical Trial Outcome Measures

Primary Measures

  • Effect on VR-biofeedback on anxiety
    • Time Frame: Before 10 minute VR session.
    • Anxiety scores will be collected. Anxiety will be rated using a visual analog scale. Anxiety will be rated from 0 – 10. 0 meaning no anxiety 10 being severe anxiety.
  • Effect on VR-biofeedback on anxiety
    • Time Frame: Immediately after VR session.
    • Anxiety scores will be collected. Anxiety will be rated using a visual analog scale. Anxiety will be rated from 0 – 10. 0 meaning no anxiety 10 being severe anxiety.
  • Effect of VR-biofeedback on pain
    • Time Frame: Postoperatively 24 – 90 hours.
    • Pain scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 – 10. 0 meaning no pain and 10 being the worst pain imaginable.
  • Effect of VR-biofeedback on medication use
    • Time Frame: Duration of hospital stay up to 30 days after discharge
    • Amount of pain medications used will be collected
  • Effect of VR-distraction on anxiety
    • Time Frame: Before 10 minute VR session.
    • Anxiety scores will be collected. Anxiety will be rated using a visual analog scale. Anxiety will be rated from 0 – 10. 0 meaning no anxiety 10 being severe anxiety.
  • Effect of VR-distraction on anxiety
    • Time Frame: Immediately after 10 minute VR session.
    • Anxiety scores will be collected. Anxiety will be rated using a visual analog scale. Anxiety will be rated from 0 – 10. 0 meaning no anxiety 10 being severe anxiety.
  • Effect of VR-distraction on pain
    • Time Frame: Postoperatively 24 – 90 hours.
    • Pain scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 – 10. 0 meaning no pain and 10 being the worst pain imaginable.
  • Effect of VR-distraction on medication use
    • Time Frame: Duration of hospital stay up to 30 days after discharge
    • Pain medications used will be collected

Secondary Measures

  • Role of anxiety on changes in pain
    • Time Frame: One time prior to study visit
    • Participants will complete a questionnaire regarding anxiety
  • Role of pain catastrophizing
    • Time Frame: One time prior to study visit
    • Participants will complete a questionnaire regarding pain

Participating in This Clinical Trial

Inclusion Criteria

  • Age 8 – 18 years
  • Able to read, understand, and speak English
  • Patients in the immediate postoperative period following laparoscopic appendectomy for ruptured appendix

Exclusion Criteria

  • Outside of age range (<8 or >18 years)
  • History of developmental delays, uncontrolled psychiatric conditions, or neurological conditions (especially epilepsy and/or significant motion sickness/nausea/vomiting)
  • History of vertigo, dizziness, and/or seizure disorders
  • Conditions that would preclude the application of the VR headset, such as craniofacial deformities
  • History of chronic pain, frequent opioid use and/or active cancer therapy

Gender Eligibility: All

Minimum Age: 8 Years

Maximum Age: 18 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Children’s Hospital Medical Center, Cincinnati
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Vanessa Olbrecht, MD, Principal Investigator, Children’s Hospital Medical Center, Cincinnati
  • Overall Contact(s)
    • Vanessa Olbrecht, MD, 513-636-4408, vanessa.olbrecht@cchmc.org

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.